Papers
Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7339.705 (Published 23 March 2002) Cite this as: BMJ 2002;324:705
Related articles
- This Week In The BMJ Published: 23 March 2002; BMJ 324 doi:10.1136/bmj.324.7339.0/b
- Letter Published: 06 July 2002; BMJ 325 doi:10.1136/bmj.325.7354.46
See more
- Diabetes UK defends partnership with Slimming World in face of criticismBMJ April 26, 2024, 385 q962; DOI: https://doi.org/10.1136/bmj.q962
- Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic testBMJ March 25, 2024, 384 q744; DOI: https://doi.org/10.1136/bmj.q744
- FDA approves first over-the-counter blood glucose monitor for diabetesBMJ March 11, 2024, 384 q611; DOI: https://doi.org/10.1136/bmj.q611
- US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDABMJ March 06, 2024, 384 q569; DOI: https://doi.org/10.1136/bmj.q569
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
Cited by...
- Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes
- Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions
- Revisiting the Relationships Between Measures of Glycemic Control and Hypoglycemia in Continuous Glucose Monitoring Data Sets
- Glucose Variability Assessed by Low Blood Glucose Index Is Predictive of Hypoglycemic Events in Patients With Type 1 Diabetes Switched to Pump Therapy
- Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial
- Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: A randomized open parallel multicenter study
- New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes
- Use of Insulin Pump Therapy in the Pediatric Age-Group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes
- Continuous Glucose Monitoring-Guided Insulin Adjustment in Children and Adolescents on Near-Physiological Insulin Regimens: A randomized controlled trial
- Point: Are Insulin Pumps Underutilized in Type 1 Diabetes? Yes.
- A Two-Center Randomized Controlled Feasibility Trial of Insulin Pump Therapy in Young Children With Diabetes
- Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections: The impact of baseline A1c
- The Impact of a Decade of Changing Treatment on Rates of Severe Hypoglycemia in a Population-Based Cohort of Children With Type 1 Diabetes
- Insulin pumps
- Insulin Pump Therapy: a Meta-Analysis: Response to Weissberg-Benchell et al.
- Both Continuous Subcutaneous Insulin Infusion and a Multiple Daily Insulin Injection Regimen With Glargine as Basal Insulin Are Equally Better Than Traditional Multiple Daily Insulin Injection Treatment
- Response to Schade: To pump or not to pump?
- To Pump or Not to Pump
- ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
- Insulin pumps are still debatable for type 1 diabetes
- Continuous Insulin Infusion Provides Better Glycemic Control